Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Primary Care Portfolio Total [legacy] by Quarter
Primary Care Portfolio Total [legacy] — Worldwide reported YoY (%) (%)
Pfizer Primary Care Portfolio Total [legacy]: -11.0% in Q4 2025, down 38.0 pts from a year earlier.
Latest, Q4 2025
-11.0%
Period ended Dec 31, 2025
Change on a year earlier
-38.0 pts
27.0% in Q4 2024
History
14 quarters
Since Q3 2022
Sources
14
Documents cited below
Where the Q4 2025 figure comes from
“|| Primary Care | $ | 7,938 | $ | 8,911 | (11%) | (13%) | $ | 3,547 | $ | 3,983 | (11%) | $ | 4,391 | $ | 4,928 | (11%) | (14%)”
Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
Reported in Form 8-K Revenue Tables.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Pfizer Primary Care Portfolio Total [legacy] (%), quarterly Q3 2022–Q4 2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/port-leg-pc-yoy
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.